Centene CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
CNC
Centene CORPCentene Corporation reported a significant net loss of $6.6 billion in Q3 2025, primarily due to a $6.7 billion goodwill impairment, despite an 18% increase in total revenues.
NYSE
CNC
Centene CORPCentene Corporation reported a significant net loss in the second quarter of 2025, primarily driven by increased medical costs and a reduction in Marketplace risk adjustment revenue estimates, despite strong revenue growth.
NYSE
CNC
Centene CORP10-Q: Centene Reports Strong Q1 2025 Earnings, Driven by Premium Growth and Efficient Cost Management
Centene Corporation announces a strong first quarter in 2025, with significant revenue growth and improved earnings per share, driven by its Medicare and Commercial segments.
NYSE
CNC
Centene CORPCentene Corporation's third-quarter results show revenue growth offset by increased medical costs and impacts from Medicaid redeterminations and Medicare Star ratings.
NYSE
CNC
Centene CORPCentene Corporation's second quarter results show a 6% year-over-year revenue increase, driven by Marketplace growth, while navigating Medicaid redeterminations.
NYSE
CNC
Centene CORPCentene Corporation's first quarter 2024 results show revenue growth and strategic adjustments amidst Medicaid redeterminations and divestitures.